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Human cells are generally thought to be nonpermissive for polyomavirus (Py) DNA replication. Using transient transfection,
we show that Py large T-antigen (LT) was able to support replication of a Py origin-containing plasmid in two human cell lines.
Replication supported by LT in human cells was specific for the Py origin and required its enhancer sequences, as well as
the previously reported critical phosphorylation sites within LT. Py replication efficiency was comparable to that of
papillomavirus E1- and E2-activated DNA replication in transient assays performed in human 293 and C-33A cells. Previous
analysis of DNA replication in vitro has pointed to polymerase a–primase as a specificity determinant for polyomavirus. The
data presented here imply that in certain cellular environments, Py LT must functionally interact with human polymerase
a–primase to permit DNA replication. © 1998 Academic Press
INTRODUCTION
To initiate replication from viral origin sequences,
papovaviruses synthesize sequence-specific DNA bind-
ing ‘‘initiator’’ proteins: large T-antigen (LT) for polyoma-
virus (Py) and E1 for papillomavirus (PV). Both these
proteins have been shown to act as helicases and to
attract host cellular factors, including DNA polymerases,
to the replication origin. While natural infection of human
and bovine PVs is highly species restricted, this speci-
ficity is not observed in transient DNA replication assays
(Dvoretzky et al., 1980; Ustav et al., 1991). In addition to
E1, which alone can support low levels of replication in
vivo and in vitro (Gopalakrishnan and Khan, 1994; Bonne-
Andrea et al., 1995; Grossel et al., 1996; Sakai et al.,
1996), PVs encode another protein, E2, that is necessary
for efficient replication of viral DNA in vivo (reviewed in
Lambert, 1991). Py replication requires only one viral
protein, LT, although middle T and small T can contribute
by their action on the host cell (Tooze, 1981; Challberg
and Kelly, 1989). In contrast to PVs, polyomavirus DNA
replication is thought to be limited to rodent cells and not
to occur in primate cells (reviewed in Tooze, 1981; Chall-
berg and Kelly, 1989). In vitro experiments suggested that
the basis for this rodent cell DNA replication specificity is
the ability of Py LT to interact with rodent- but not with
primate-derived polymerase a–primase complex (pol a–
primase) (Murakami et al., 1986; Eki et al., 1991; Stadl-
bauer et al., 1994; Bruckner et al., 1995). During our
studies of DNA replication, using transient transfection
and acquisition of DpnI resistance as the assay, we
observed that Py LT supported efficient replication of Py
origin-containing plasmids in some human cell lines.
MATERIALS AND METHODS
Plasmid DNAs
BPV-1 replication assays used BPV-1 origin plasmid
pUCLCR-BPV (Sverdrup and Khan, 1994), E2 expression
plasmid pCGE2, and E1 expression plasmid pCGEAg
(Ustav and Stenlund, 1991). Polyomavirus assays in-
cluded Py origin plasmid pUCori and either Py LT ex-
pression plasmid pCMV-LT or pCMV-CT (Gjoerup et al.,
1994). pUC19 was used as an origin-negative control.
SV40 samples included SV40 origin plasmid pSV01EP
(Wobbe et al., 1985) and SV40 large T-antigen expression
plasmid pRSV-TEX (Loeken et al., 1988). Expression plas-
mids utilized the cytomegalovirus early promoter to di-
rect expression of inserted genes except for pRSV-TEX,
in which SV40 T-antigen is expressed from the RSV LTR.
Empty CMV expression vector pCG (Tanaka and Herr,
1990) was added to each sample to a total of 4 mg
expression vector.
Cell culture
Human cervical carcinoma C33A cells, adenovirus-
transformed human embryonic kidney 293 cells, monkey
CV-1 cells, and mouse NIH 3T3 cells were grown in
Dulbecco’s modified Eagle’s medium supplemented with
10% fetal calf serum, penicillin (100 U/ml), and strepto-
mycin (100 mg/ml).
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DNA replication assays and protein analysis
For replication, 2 3 105 to 5 3 105 cells were seeded per
60-mm dish. Sixteen hours after seeding, cells were trans-
fected by calcium phosphate coprecipitation (Chen and
Okayama, 1987). Three days after transfection, low-molec-
ular-weight DNA was isolated by the method of Hirt (1967)
and linearized with EcoRI. To distinguish between repli-
cated and unreplicated DNA, one-half of each sample was
treated with an excess of DpnI to remove the unreplicated,
input methylated DNA (Peden et al., 1980). The DNA sam-
ples were analyzed by electrophoresis in 0.7% agarose gels
using Tris–borate–EDTA buffer followed by Southern blot
hybridization (Sambrook et al., 1989). All plasmids included
pUC19-derived sequences and therefore pUC19 served as
the detection probe. For the blots shown in Figs. 1 and 4,
labeling with 32P was performed using a random primer
labeling kit (Pharmacia Biotech). For Figs. 2 and 3, the
pUC19 probe was labeled with digoxigenin–dUTP and the
blots were subjected to chemiluminescent detection (Ge-
nius system, Boehringer-Mannheim). Blots were analyzed
using a Bio-Rad Molecular Imager and exposure to BioMax
MR film (Eastman Kodak).
Western analysis of T-antigen levels in cell lysates was
performed as previously described (Chatterjee et al., 1997).
Protein was detected by enhanced chemiluminescence.
RESULTS
Species preference for replication of papovavirus DNA
Transient replication analyses were first performed
using mouse NIH 3T3 and monkey CV-1 cells. These cell
lines were chosen because they have been previously
used to analyze the requirements for species-specific
papovavirus replication (Bennett et al., 1989). Plasmids
containing viral origins and expression vectors for viral
replication proteins were transfected by calcium phos-
phate coprecipitation with an efficiency of approximately
10% for both cell lines as estimated by staining after
transfection with a b-gal-expression plasmid. The results
of transient replication analyses in mouse NIH 3T3 cells
are shown in the left portion of the Southern blot in Fig.
1. Each DNA sample is present in two lanes, where the
first lane represents one-half of the total linearized DNA
and the second lane represents DpnI-resistant repli-
cated DNA. The BPV-1 origin plasmid replicated in 3T3
cells when cotransfected with the BPV-1 E1 and E2
expression plasmids, as evidenced by DpnI resistance of
the origin band (Fig. 1, lane 2). The lack of DpnI resis-
tance of the upper plasmid bands lacking the origin (E1
and E2 expression plasmids) shows the specificity of the
assay for origin-containing plasmids. When cotrans-
fected with the LT expression vector, the Py origin plas-
mid replicated approximately as efficiently as the BPV-1
DNA (Fig. 1, lanes 6 and 8). When the SV40 large T-
antigen was expressed in NIH 3T3 cells, only limited
replication of its cognate origin plasmid was detected as
DpnI-resistant origin bands (Fig. 1, lanes 10 and 12).
In monkey CV-1 cells, the situation was different. As
expected, the Py origin plasmid was completely DpnI
sensitive in the absence of LT expression vector, indi-
cating that it did not replicate (Fig. 1, lanes 15 and 16). In
the presence of LT expression vector, a low level of
FIG. 1. Replication of Py and SV40 DNA in mouse NIH 3T3 and monkey CV-1 cells. NIH 3T3 (lanes 1–12) and CV-1 cells (lanes 13–24) were
transfected by calcium phosphate coprecipitation with 5 mg of the following origin plasmids: BPV-1 ori plasmid pUCLCR-BPV (lanes 1 and 2, 13 and
14), Py origin plasmid pUCori (lanes 3–8, 15–20), or SV40 origin plasmid pSV01rep (lanes 9–12, 21–24). The BPV-1 samples contained 1 mg of E2
expression plasmid and 3 mg of E1 expression plasmid. Py samples contained either no LT expression plasmid (lanes 3 and 4, 15 and 16) or 0.5 mg
(lanes 5 and 6, 17 and 18) or 2.5 mg (lanes 7 and 8, 19 and 20) of LT expression plasmid. SV40 samples included 0.5 mg (lanes 9 and 10, 21 and 22)
or 2.5 mg (lanes 11 and 12, 23 and 24) of SV40 T-ag expression plasmid. Empty pCG vector was added to each sample to bring the total amount of
CMV promoter-containing plasmids to 4 mg. Each sample is present in two lanes, where the first lane represents linearized DNA and the second lane
represents linearized DNA treated with an excess of DpnI. The Southern blot was probed with pUC19 DNA and the positions of bands corresponding
to origin plasmids are indicated.
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replication was detected, as evidenced by DpnI-resistant
Py origin bands (Fig. 1, lanes 18 and 20). Replication of
the Py origin plasmid was approximately eight fold
greater in NIH 3T3 cells than in CV-1 cells under these
particular conditions (Fig. 1, compare lanes 5–8 with
lanes 17–20). The lower level of replication in CV-1 cells
was still origin dependent (data not shown). The SV40
origin plasmid replicated to such high levels in CV-1 cells
when cotransfected with an SV40 T-antigen expression
vector that the signal from the amplified product ex-
ceeded the capacity of the imager at this length of
exposure (Fig. 1, lanes 21–24). This extremely high level
of transient replication is consistent with previous stud-
ies of SV40 replication in CV-1 cells (Campbell and Vil-
larreal, 1985; Tang and Folk, 1989). The slower migrating,
partially DpnI-resistant bands in the SV40 samples rep-
resent empty pCG vector which was added to each
sample to bring the total amount of vector transfected to
4 mg. pCG contains the SV40 origin, and its EcoRI diges-
tion product comigrates with that of the SV40 T-antigen
expression vector. It is worth noting that BPV-1 replica-
tion was inefficient in CV-1 cells under these conditions
(Fig. 1, lanes 13 and 14). These results demonstrate that
origin-dependent replication supported by Py LT shows a
strong preference for mouse NIH 3T3 cells compared to
monkey CV-1 cells, while replication of SV40 DNA occurs
efficiently only in CV-1 cells. These results are consistent
with the apparently species-specific replication of Py and
SV40 DNA in these and other cell lines (Tooze, 1981;
Challberg and Kelly, 1989).
Replication of polyomavirus DNA in human C-33A
cells
Transient replication analyses were performed using
the human cervical carcinoma cell line C-33A. These
cells have previously been shown to support highly effi-
cient replication of PV DNAs (Chiang et al., 1992a, b;
Sverdrup and Khan, 1994, 1995). Plasmids were again
transfected by calcium phosphate coprecipitation with
an efficiency of 20–30%. The capabilities of PV and Py
proteins to stimulate transient replication of their respec-
tive origin-containing plasmids in human C-33A cells are
shown in the Southern blot in Fig. 2. The BPV-1 origin
plasmid replicated when cotransfected with the BPV-1
E1 and E2 expression plasmids, as evidenced by DpnI
resistance of the origin band (Fig. 2, lane 2). The bands
corresponding to the E1 and E2 expression vectors were
again completely sensitive to DpnI digestion, indicating
they had not replicated. With cotransfection of 0.5 or 2.5
mg of polyomavirus LT expression vector and the Py
origin plasmid pUCori, efficient replication was detected
as DpnI-resistant origin bands (Fig. 2, lanes 6 and 8).
When an expression vector for LT was cotransfected
with pUC19 as an origin-negative control, the pUC19
DNA did not replicate, indicating specificity of LT for
origin DNA (Fig. 2, lanes 3 and 4). Because these results
demonstrating Py DNA replication in a human cell line
were surprising, we looked at additional aspects of Py
replication. It has recently been shown that the carboxy-
terminal domain of LT (CT) comprising amino acids 264–
785 possesses all the activities necessary for transient
replication of Py origin plasmids in mouse cells (Gjoerup
et al., 1994). Cotransfection of an expression vector for
CT also resulted in efficient replication of pUCori in
human C-33A cells (Fig. 2, lanes 9 and 10). A quadruple
phosphorylation site mutant of CT (CT-mut) which is
defective for replication in mouse cells (Chatterjee et al.,
1997) was also defective for replication in C-33A cells
(Fig. 2, lanes 11–14). As additional specificity controls,
we observed that Py LT did not support replication of the
BPV-1 origin plasmid and BPV-1 E1 and E2 did not sup-
port replication of the Py origin plasmid (unpublished
observations). Finally, we investigated whether the rep-
lication observed in C-33A cells required the enhancer
region of the origin. An enhancer region located adjacent
to the core origin of Py is required for origin activity in
mouse cells (Tyndall et al., 1981; Muller et al., 1983, 1988;
de Villiers et al., 1984; Veldman et al., 1985; Hassell et al.,
1986; Mueller et al., 1988). An origin plasmid that was
devoid of known enhancer sequences but included the
core origin of Py was constructed to contain Py se-
quences from 5268–163. This plasmid failed to replicate
when cotransfected with CT or LT expression vectors
(data not shown), indicating a requirement for the en-
hancer region for origin activity in human C-33A cells.
These data demonstrate that Py large T-antigen can
FIG. 2. Transient replication of Py DNA in human C-33A cells. For
each 60-mm dish, 0.5 mg of BPV-1 ori plasmid pUCLCR-BPV (lanes 1
and 2), origin-negative pUC19 (lanes 3 and 4), or Py origin plasmid
pUCori (lanes 5–14) was cotransfected with expression plasmids. The
BPV-1 sample contained 1 mg of E2 expression plasmid and 3 mg of E1
expression plasmid. Py samples contained either 0.5 mg (lanes 3–6) or
2.5 mg (lanes 7 and 8) of LT expression plasmid, 2.5 mg of CT expres-
sion plasmid (lanes 9 and 10), or 0.5 mg (lanes 11 and 12) or 2.5 mg
(lanes 13 and 14) of CT-mut expression plasmid. Each sample is
present in two lanes, where the first lane represents linearized DNA
and the second lane represents linearized DNA treated with an excess
of DpnI. The Southern blot was probed with pUC19 DNA and the
positions of bands corresponding to origin plasmids are indicated.
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support origin-dependent plasmid replication in a human
cell line with an efficiency comparable to that of BPV
replication.
Replication of polyomavirus DNA in human 293 cells
To investigate whether Py DNA could replicate in other
human cells, analogous experiments were performed in
the adenovirus-transformed human embryonic kidney
cell line 293. This cell line is of significance because
S100 cytosolic extracts from these cells did not support
efficient replication of Py DNA in vitro in the presence of
purified LT, and the addition of pol a–primase purified
from a rodent source was necessary to permit efficient
Py DNA replication (Eki et al., 1991; Bruckner et al., 1995).
The 293 cells were transiently transfected as described
above for C-33A cells. We found that both LT and CT
supported efficient replication of the origin plasmid in
transiently transfected 293 cells (Fig. 3, lanes 7–14). As in
C-33A cells, an origin and functional T-antigen were
required for replication to occur (Fig. 3, lanes 3–6 and
15–18).
Comparison of LT levels in 3T3 versus C-33A cells
Since the expression of LT in the transient transfection
assays shown here is directed by the strong CMV pro-
moter, it is possible that synthesis of large amounts of LT
in C-33A cells was driving an interaction with human pol
a–primase that might not occur at lower levels of LT. In
order to test this hypothesis, we monitored the levels of
LT during replication of Py DNA in 3T3 and C-33A cells
over a range of input LT expression vector levels. Repli-
cation of the Py origin plasmid in human C-33A cells was
most efficient at the lowest input amount (0.1 mg) of LT
expression vector, while replication efficiency in mouse
3T3 cells increased with higher input amounts (Fig. 4A).
Importantly, there was significant replication in human
C-33A cells when large T-antigen production was com-
parable to that obtained in 3T3 cells (Figs. 4A and 4B).
Production of higher levels of LT was inhibitory for Py
DNA replication in human cells (Figs. 4A and 4B). These
data indicate that the replication of Py DNA in human
C-33A cells is not simply due to the expression of ex-
traordinarily high levels of LT.
DISCUSSION
We show here that Py LT does function as an origin-
specific initiator of DNA replication in human 293 and
C-33A cells. In additional experiments, we detected rep-
lication of Py DNA in human HeLa cells, albeit at lower
levels than in 293 and C-33A cells (unpublished obser-
vations). A low level of Py DNA replication in HeLa cells
was previously reported using an SV40–Py hybrid origin
(de Villiers et al., 1982), but this was refuted by others
(Campbell and Villarreal, 1985). A similar result showing
polyomavirus DNA replication in primate cells has pre-
viously been obtained in COS cells, a CV-1-derived cell
line that expresses SV40 large T (Tang and Folk, 1989).
These results are complicated by the presence of SV40
large T in COS cells. The interpretation of the data rests
on whether mixed oligomers of the SV40 and polyoma
T-antigens that might function in replication can be
formed. The authors did favor a model in which a slow
FIG. 4. Comparison of large T levels in 3T3 versus C-33A cells. Py
origin-containing plasmid pUCori (0.5 mg) was cotransfected into
mouse 3T3 cells and human C-33A cells with the indicated amounts of
LT expression vector. Empty expression vector was added to a total of
4.5 mg CMV expression vector per 60-mm dish. All samples were
transfected in duplicate. (A) Replication of pUCori in 3T3 and C-33A
cells. One dish from each duplicate sample was harvested for Southern
blot analysis of replication products as described under Materials and
Methods. (B) Western blot. The second dish of each duplicate sample
was harvested for Western analysis of LT levels as previously de-
scribed (Chatterjee et al., 1997).
FIG. 3. Transient replication of Py DNA in human 293 cells. 0.5 mg of
the following origin plasmids was cotransfected with expression plas-
mids: BPV-1 ori plasmid pUCLCR-BPV (lanes 1 and 2), origin-negative
pUC19 (lanes 3 and 4), or Py origin plasmid pUCori (lanes 5–18). The
BPV-1 sample contained 1 mg of E2 expression plasmid and 3 mg of E1
expression plasmid. Py samples contained either 0.5 mg (lanes 3 and
4, 7 and 8) or 2.5 mg (lanes 9 and 10) of LT expression plasmid, 0.5 mg
(lanes 11 and 12) or 2.5 mg (lanes 13 and 14) of CT expression plasmid,
or 0.5 mg (lanes 15 and 16) or 2.5 mg (lanes 17 and 18) of CT-mut
expression plasmid. Each sample is present in two lanes, where the
first lane represents linearized DNA and the second lane represents
linearized DNA treated with an excess of DpnI. The Southern blot was
probed with pUC19 DNA and the positions of bands corresponding to
origin plasmids are indicated.
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modification process in the cell in response to SV40
large T enables the cellular replication machinery to
permit polyoma DNA replication.
The interaction of polyomavirus with human cells has
not been critically examined, probably because it was
recognized early on that the virus neither transformed
nor grew in human cells (Eddy, 1969). It is apparent that
in some cells there is some block in virus penetration,
since injection of viral DNA, but not infection with virus,
results in T-antigen synthesis (Gruen et al., 1974). How-
ever, in other cells, notably fibroblasts, T-antigen could
be detected after infection; strikingly, T-antigen expres-
sion was dramatically higher when transformed cells
were used (Takemoto et al., 1978). Examination of hu-
man–mouse hybrids suggested that the ability to repli-
cate was associated with retention of mouse chromo-
somes, but it was not possible to map the locus required
for permissivity (Huebner et al., 1977). In none of the
earlier studies was viral DNA replication directly mea-
sured. Late capsid antigen was not detected, so the
assumption was that the block is at the level of DNA
replication. However, work of Carmichael’s group has
shown that the accumulation of late mRNA requires not
merely DNA replication, but also sufficient DNA replica-
tion to allow titration of some cellular factor (Liu and
Carmichael, 1993). In human cells, a quantitative de-
crease in DNA replication or increase in expression of a
cellular regulatory factor could result in the observations
that were made.
In vitro analysis of Py DNA replication has been the
principal approach to sorting out the basis for permis-
sivity. The in vivo results presented here stand in contrast
to results obtained using in vitro DNA replication. Spe-
cifically, the replication of Py DNA in 293 cells in vivo
appears to differ from in vitro results with 293 cell ex-
tracts which were nonpermissive for Py DNA replication
(Eki et al., 1991; Bruckner et al., 1995). The in vitro exper-
iments have suggested pol a–primase as the specificity
determinant (Murakami et al., 1986; Wobbe et al., 1987;
Eki et al., 1991; Schneider et al., 1994; Bruckner et al.,
1995). In particular, recent experiments of Bruckner and
colleagues have implicated the p48 subunit of the pol
a–primase complex in the failure of polyoma DNA to
replicate in human 293 cell extracts (Bruckner et al.,
1995). However, one aspect of these experiments is
intriguing. Normal S-100 extracts of 293 cells were able
to support a low level of Py replication, while depletion of
human pol a–primase from these extracts abolished
replication (Bruckner et al., 1995). Recombinant human
pol a–primase was not able to restore the low level of
replication that was previously observed, indicating that
some aspect of the in vitro system had changed (Bruck-
ner et al., 1995). Other contrasts between in vivo and in
vitro results have been seen before. For instance, ham-
ster V79 cells are semipermissive for both Py and SV40
propagation (Tooze, 1981), yet extracts from these cells
support replication of only Py DNA (Eki et al., 1991).
What differences might there be between the two
kinds of experiments? One possibility is that the in vivo
replication is a consequence of overexpression of large
T. It could be imagined that high-level expression of
murine polyoma large T from a strong promoter might
drive an interaction with human pol a–primase that is of
an affinity intrinsically lower than that with the murine
enzyme. If so, it is the in vitro demonstrations of speci-
ficity that are puzzling. The amounts of large T used in in
vitro DNA replication assays are quite high. Titration of
replication in our transfection assays along with Western
analysis of T-antigen production suggests that replica-
tion is obtained in C-33A or 293 cells when large T levels
are comparable to those in 3T3 cells (see Fig. 4 and
unpublished observations). In fact, replication of Py DNA
in C-33A cells occurred preferentially at lower levels of
LT while higher levels were inhibitory.
There is an additional, more interesting, possibility:
permissivity is significantly determined by the state of the
cell. Clearly there is precedence for this. For example,
human embryonic kidney cells (HEK) replicate SV40 DNA
poorly or not at all, but the adenovirus-transformed HEK
cell line 293 replicates SV40 DNA efficiently (Lebkowski
et al., 1985; Lewis and Manley, 1985). For polyomavirus,
the CT is sufficient for replication in growing but not
serum-starved mouse cells (Gjoerup et al., 1994). It is
well known that the ability of large T to drive viral repli-
cation can be dramatically increased by the expression
of middle T and small T (Turler and Salomon, 1985;
Berger and Wintersberger, 1986). If replication results
from changes in patterns of cellular expression, the data
presented here demonstrating Py replication in human
C-33A cells (Fig. 2) indicate that viral oncogenes are not
required. C-33A cervical carcinoma cells are not known
to contain any viral oncogenes; instead they possess
mutations in the genes for p53 and pRb (Crook et al.,
1991; Scheffner et al., 1991).
What might be different about the cell state? It is
tempting to speculate that one important difference in
the assays is the modification of the proteins involved in
replication. Certainly the abilities of the large T-antigens
of SV40 and Py to function in replication are regulated by
phosphorylation. In the case of SV40, threonine 124 is a
critical target of cyclin/cdk kinases (McVey et al., 1993).
Phosphorylations at serines can be negatively regulating
(Cegielska et al., 1994). Polyoma large T contains two
clustered sites of phosphorylation (Bockus and Schaff-
hausen, 1987) and its replication activities are regulated
by phosphorylation (Wang et al., 1993; Chatterjee et al.,
1997). Also, the activation of CT replication in growing
cells is associated with its phosphorylation (Gjoerup et
al., 1994). The polymerase a–primase complex is another
likely target of regulation by phosphorylation. For exam-
ple, the catalytic properties of pol a–primase in vitro are
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affected by phosphorylation (Krauss et al., 1987) and
phosphorylation of pol a–primase in a cell-cycle-depen-
dent manner correlates with changes in activity in vivo
(Nasheuer et al., 1991). It is interesting that only a fraction
of pol a–primase isolated from mouse cells is able to
physically and functionally interact with Py LT (Moses
and Prives, 1994). This implies that either modifications
of pol a–primase or its associations with unidentified
cofactors play a major role in permitting functional inter-
actions between Py LT and the replication machinery of
murine origin. It is easy to imagine that there are differ-
ences in modification patterns between in vivo and in
vitro replication systems. Further work will be required to
confirm this and to sort out which difference might be
critical.
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